BridgeBio Pharma, Inc. (BBIO)
65.36
-0.81
(-1.22%)
USD |
NASDAQ |
Mar 06, 16:00
65.32
-0.04
(-0.06%)
After-Hours: 20:00
BridgeBio Pharma SG&A Expense (TTM) : 531.22M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Insmed, Inc. | 701.17M |
| Mirum Pharmaceuticals, Inc. | 257.03M |
| Alphatec Holdings, Inc. | 498.53M |
| Supernus Pharmaceuticals, Inc. | 485.56M |
| Cogent Biosciences, Inc. | 63.58M |